BiotechTube
Home/Nykode Therapeutics/Trygve Lauvdal
TL

Trygve Lauvdal

Board Member

Nykode Therapeutics

Therapeutic Areas

OncologyAutoimmune DiseasesInfectious Diseases

Nykode Therapeutics Pipeline

DrugIndicationPhase
VB10.16HPV16-positive cancersPhase 2
VB10.NEOLocally advanced and metastatic tumors (individualized)Phase 1b

Leadership Team at Nykode Therapeutics

DB
Dr. Barbara Krebs-Pohl
Chair of the Board
DJ
Dr. John Beadle
Board Member
SS
Susanne Stuffers
Board Member
CÅ
Christian Åbyholm
Board Member
View full Nykode Therapeutics profile